As per the current market research conducted by the CMI Team, the global Disease Management Apps Market size is expected to record a CAGR of 11.6% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 10,287.8 Million. By 2033, the valuation is anticipated to reach USD 27,625.1 Million.

Disease Management Apps Market: Growth Factors and Dynamics

  • Rising Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular disorders is driving the demand for disease management apps, as they provide patients with tools to monitor their conditions, track symptoms, and adhere to treatment plans remotely.
  • Advancements in Mobile Technology: Advancements in mobile technology, including smartphones, wearables, and IoT devices, have enabled the development of sophisticated disease management apps with features like real-time data tracking, personalized recommendations, and integration with electronic health records (EHRs), enhancing patient engagement and outcomes.
  • Growing Emphasis on Preventive Healthcare: There is a growing emphasis on preventive healthcare and proactive management of health conditions, leading to increased adoption of disease management apps for early detection, lifestyle interventions, and behavior modification to mitigate disease risks and improve overall wellness.
  • Telehealth and Remote Patient Monitoring: The COVID-19 pandemic has accelerated the adoption of telehealth and remote patient monitoring solutions, including disease management apps, as they allow healthcare providers to remotely monitor patients, deliver virtual consultations, and optimize care delivery without physical contact, ensuring continuity of care during lockdowns and social distancing measures.
  • Focus on Patient-Centric Care: Healthcare industry trends towards patient-centric care models emphasize the importance of empowering patients to actively participate in their healthcare journey. Disease management apps facilitate patient engagement, education, and self-management, empowering individuals to take control of their health and make informed decisions in collaboration with healthcare professionals.

Get Free Sample Copy @ https://www.custommarketinsights.com/request-for-free-sample/?reportid=50811

Disease Management Apps Market: Partnership and Acquisitions

  • In 2023, Lupin, a global pharmaceutical leader, announced the launch of Vilfuro-G, the first-ever fixed-dose triple combination medication, in India for treating chronic obstructive pulmonary disease (COPD). Vilfuro-G offers once-daily treatment for COPD, addressing airflow obstruction and breathing difficulties, in a single-strength fixed dose.
  • In 2022, Abbott unveiled Neurosphere myPath, a digital health application tailored for individuals with chronic pain eligible for Dorsal Root Ganglion (DRG) or Spinal Cord Stimulation (SCS) therapy. This innovative app enables personalized monitoring and treatment, enhancing the management of chronic pain conditions.
  • In 2021, Apple Inc. unveiled Apple Fitness+, a new software designed for the Apple Watch, offering personalized motivation, tracking, and guided workouts across various categories such as HIIT, yoga, rowing, dancing, cycling, strength, and more, accessible on iPad, iPhone, and Apple TV platforms.

Disease Management Apps Market: COVID-19 Analysis

The COVID-19 pandemic has significantly impacted the Disease Management Apps Market, with the industry experiencing both positive and negative effects. Here are some of the key impacts:

  • Increased Demand for Remote Monitoring: The COVID-19 pandemic has accelerated the adoption of disease management apps as healthcare systems sought remote monitoring solutions to minimize in-person visits and reduce the risk of virus transmission. Patients and healthcare providers increasingly relied on these apps for remote symptom tracking, medication adherence, and virtual consultations.
  • Shift Towards Telehealth Services: With the surge in telehealth services during the pandemic, disease management apps have become essential tools for delivering remote care and monitoring patients’ health status. Telehealth platforms integrated with disease management apps allowed for seamless virtual consultations, enabling healthcare providers to continue delivering care while adhering to social distancing guidelines.

List of the prominent players in the Disease Management Apps Market:

  • Livongo Health (now part of Teladoc Health)
  • Omada Health
  • WellDoc Inc.
  • Propeller Health (part of ResMed)
  • MyFitnessPal (part of Under Armour)
  • One Drop
  • Medisafe
  • BlueStar (by Welldoc)
  • Mango Health
  • Ada Health
  • MySugr (part of Roche Diabetes Care)
  • Headspace
  • BetterHelp (part of Teladoc Health)
  • Cerner Corporation
  • Fitbit (part of Google)
  • Others

Table of Contents: https://www.custommarketinsights.com/report/disease-management-apps-market/#table-of-contents

About Us:

Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains.

Custom Market Insights provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey.

Contact Us:

USA Corporate Office

CMI Consulting LLC

1333, 701 Tillery Street Unit 12, Austin, TX, Travis, US, 78702
Sales & Support +1 801 639 9061

Email : support@custommarketinsights.com

Website : https://www.custommarketinsights.com/